Company Data

Kiniksa Pharmaceuticals Ltd.

Ticker
KNSA
Current Price
$20.01 2.35%
Market Cap
$1.4B
Price Target
Refer to Report
Volume
202.8K
52wk Range
$16.56 - $28.15
Advanced Market Data

Overview

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy